PARP Inhibitor

10-year results of BIG 2-04 SUPREMO trial – Breast International Group

Breast International Group shared a post on X:

“New article published in the ASCO Post on 10-year results of BIG 2-04 SUPREMO trial. Read it now.”

ASCO Breast Cancer Breast International Group cancer OncoDaily Oncology SUPREMO trial The ASCO Post